Carole Longson
Directeur/Membre du Conseil chez Peter Sowerby Foundation
Profil
Carole Longson currently works at Medicines Discovery Catapult Ltd., as Vice Chairman, Genesis Research LLC, as Director from 2022, and Peter Sowerby Foundation, as Trustee.
Postes actifs de Carole Longson
| Sociétés | Poste | Début |
|---|---|---|
Peter Sowerby Foundation
 Peter Sowerby Foundation Miscellaneous Commercial ServicesCommercial Services The Peter Sowerby Foundation is a philanthropic organization that supports innovative projects using technology effectively. The foundation is based in London, UK and was founded in 2011 by Peter Sowerby, who was also the creator of the software behind EMIS, the largest supplier of clinical software to GPs in the UK. The foundation was established with a generous endowment by Dr. Peter Sowerby to fulfill his charitable priorities. The trustees of the foundation seek to support projects that can provide maximum impact from the funds provided and measure the impact of the foundation as a whole. | Directeur/Membre du Conseil | - |
Medicines Discovery Catapult Ltd.
 Medicines Discovery Catapult Ltd. Miscellaneous Commercial ServicesCommercial Services Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy. | Directeur/Membre du Conseil | - |
Genesis Research LLC
 Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Directeur/Membre du Conseil | 17/01/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Peter Sowerby Foundation
Peter Sowerby Foundation Miscellaneous Commercial ServicesCommercial Services The Peter Sowerby Foundation is a philanthropic organization that supports innovative projects using technology effectively. The foundation is based in London, UK and was founded in 2011 by Peter Sowerby, who was also the creator of the software behind EMIS, the largest supplier of clinical software to GPs in the UK. The foundation was established with a generous endowment by Dr. Peter Sowerby to fulfill his charitable priorities. The trustees of the foundation seek to support projects that can provide maximum impact from the funds provided and measure the impact of the foundation as a whole. | Commercial Services |
Medicines Discovery Catapult Ltd.
Medicines Discovery Catapult Ltd. Miscellaneous Commercial ServicesCommercial Services Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy. | Commercial Services |
Genesis Research LLC
Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Commercial Services |